Literature DB >> 11818428

Seniors' preferences for cancer screening and medication use based on absolute risk reduction.

Donald J Murphy1, Gregory J Gahm, Sara Santilli, Patricia North, Scott C N Oliver, Howard Shapiro.   

Abstract

BACKGROUND: This study was conducted to determine the influence of patient perceptions of absolute risk on choices for cancer screening and use of medications to prevent heart attack, stroke, and hip fracture.
METHODS: At the end of routine office visits, we surveyed all eligible consecutive patients who visited four geriatricians in a Denver practice between November 8, 1993, and February 9, 1994.
RESULTS: We saw a total of 675 outpatients during the study period and completed the interview with 409 patients (75% female, mean age 81, 78% Caucasian). We found a strong correlation between (i) increased probability of detecting cancer and greater preference for cancer screening tests (p <.001) and (ii) increased probability of preventing disease (heart attack, stroke, or hip fracture) and greater preference for preventive medication (p <.0001). There was notable variability in seniors' preferences for a given therapy at each absolute risk threshold. For example, 15% of seniors did not think that highly effective, inexpensive medications to prevent heart attacks were worthwhile for them. At the other end of the spectrum, 22% of seniors felt that low-yield, costly medications to prevent heart attacks were worthwhile.
CONCLUSIONS: Seniors readily understand the probability of benefit expressed in terms of absolute risk reduction. Furthermore, probability of benefit strongly influences seniors' preferences for cancer screening and preventive medication use. Finally, there is variety in the thresholds of prevention at which individuals are willing to accept preventive treatment. The probability of benefit is an essential and useful element for seniors to make informed decisions about routine health services.

Entities:  

Mesh:

Year:  2002        PMID: 11818428     DOI: 10.1093/gerona/57.2.m100

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  7 in total

1.  Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention.

Authors:  Terri R Fried; Mary E Tinetti; Virginia Towle; John R O'Leary; Lynne Iannone
Journal:  Arch Intern Med       Date:  2011-02-28

2.  Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions.

Authors:  Terri R Fried; Mary E Tinetti; Lynne Iannone
Journal:  Arch Intern Med       Date:  2010-09-13

3.  Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

Authors:  B Dawson-Hughes; A N A Tosteson; L J Melton; S Baim; M J Favus; S Khosla; R L Lindsay
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

4.  Views of older persons with multiple morbidities on competing outcomes and clinical decision-making.

Authors:  Terri R Fried; Sarah McGraw; Joseph V Agostini; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2008-09-02       Impact factor: 5.562

5.  Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea.

Authors:  Samaneh Khanpour Ardestani; Joan L Robinson; Levinus A Dieleman; Hien Q Huynh; Hsing Jou; Sunita Vohra
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

6.  Development of an Electronic Tool to Assess Patient Preferences in Geriatric Polypharmacy (PolyPref).

Authors:  Annette Eidam; Anja Roth; Eduard Frick; Michael Metzner; Anette Lampert; Hanna M Seidling; Walter E Haefeli; Jürgen M Bauer
Journal:  Patient Prefer Adherence       Date:  2022-07-23       Impact factor: 2.314

Review 7.  Methods to Assess Patient Preferences in Old Age Pharmacotherapy - A Systematic Review.

Authors:  Annette Eidam; Anja Roth; André Lacroix; Sabine Goisser; Hanna M Seidling; Walter E Haefeli; Jürgen M Bauer
Journal:  Patient Prefer Adherence       Date:  2020-03-04       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.